ID   DPOLQ_HUMAN             Reviewed;        2590 AA.
AC   O75417; O95160; Q6VMB5;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   08-MAR-2011, sequence version 2.
DT   28-JUN-2023, entry version 165.
DE   RecName: Full=DNA polymerase theta {ECO:0000303|PubMed:10395804, ECO:0000303|PubMed:14576298, ECO:0000312|HGNC:HGNC:9186};
DE            EC=2.7.7.7 {ECO:0000269|PubMed:14576298, ECO:0000269|PubMed:22135286};
DE   AltName: Full=DNA polymerase eta {ECO:0000303|Ref.4};
GN   Name=POLQ {ECO:0000303|PubMed:10395804, ECO:0000303|PubMed:14576298,
GN   ECO:0000312|HGNC:HGNC:9186}; Synonyms=POLH {ECO:0000303|Ref.4};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=10395804; DOI=10.1006/geno.1999.5843;
RA   Sharief F.S., Vojta P.J., Ropp P.A., Copeland W.C.;
RT   "Cloning and chromosomal mapping of the human DNA polymerase theta (POLQ),
RT   the eighth human DNA polymerase.";
RL   Genomics 59:90-96(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   CATALYTIC ACTIVITY.
RX   PubMed=14576298; DOI=10.1093/nar/gkg814;
RA   Seki M., Marini F., Wood R.D.;
RT   "POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human
RT   cells.";
RL   Nucleic Acids Res. 31:6117-6126(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1435-2590.
RA   Harris P.V., Kaelin C.B., Burtis K.C.;
RT   "Catalytic activity of Pol eta, a new human DNA polymerase related to the
RT   bacterial DNA polymerase I family and Drosophila Mus308.";
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION.
RX   PubMed=18503084; DOI=10.1093/nar/gkn310;
RA   Arana M.E., Seki M., Wood R.D., Rogozin I.B., Kunkel T.A.;
RT   "Low-fidelity DNA synthesis by human DNA polymerase theta.";
RL   Nucleic Acids Res. 36:3847-3856(2008).
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF 2540-ASP-GLU-2541.
RX   PubMed=19188258; DOI=10.1093/nar/gkp035;
RA   Prasad R., Longley M.J., Sharief F.S., Hou E.W., Copeland W.C.,
RA   Wilson S.H.;
RT   "Human DNA polymerase theta possesses 5'-dRP lyase activity and functions
RT   in single-nucleotide base excision repair in vitro.";
RL   Nucleic Acids Res. 37:1868-1877(2009).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-990, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   INVOLVEMENT IN BC.
RX   PubMed=20700469; DOI=10.18632/oncotarget.124;
RA   Higgins G.S., Harris A.L., Prevo R., Helleday T., McKenna W.G., Buffa F.M.;
RT   "Overexpression of POLQ confers a poor prognosis in early breast cancer
RT   patients.";
RL   Oncotarget 1:175-184(2010).
RN   [9]
RP   INVOLVEMENT IN BC.
RX   PubMed=20624954; DOI=10.1073/pnas.0910759107;
RA   Lemee F., Bergoglio V., Fernandez-Vidal A., Machado-Silva A.,
RA   Pillaire M.J., Bieth A., Gentil C., Baker L., Martin A.L., Leduc C.,
RA   Lam E., Magdeleine E., Filleron T., Oumouhou N., Kaina B., Seki M.,
RA   Grimal F., Lacroix-Triki M., Thompson A., Roche H., Bourdon J.C.,
RA   Wood R.D., Hoffmann J.S., Cazaux C.;
RT   "DNA polymerase theta up-regulation is associated with poor survival in
RT   breast cancer, perturbs DNA replication, and promotes genetic
RT   instability.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:13390-13395(2010).
RN   [10]
RP   FUNCTION.
RX   PubMed=21050863; DOI=10.1016/j.jmb.2010.10.041;
RA   Hogg M., Seki M., Wood R.D., Doublie S., Wallace S.S.;
RT   "Lesion bypass activity of DNA polymerase theta (POLQ) is an intrinsic
RT   property of the pol domain and depends on unique sequence inserts.";
RL   J. Mol. Biol. 405:642-652(2011).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22135286; DOI=10.1093/nar/gkr1102;
RA   Hogg M., Sauer-Eriksson A.E., Johansson E.;
RT   "Promiscuous DNA synthesis by human DNA polymerase theta.";
RL   Nucleic Acids Res. 40:2611-2622(2012).
RN   [12]
RP   INVOLVEMENT IN BC.
RX   PubMed=25409685; DOI=10.1186/1471-2407-14-850;
RA   Brandalize A.P., Schueler-Faccini L., Hoffmann J.S., Caleffi M., Cazaux C.,
RA   Ashton-Prolla P.;
RT   "A DNA repair variant in POLQ (c.-1060A > G) is associated to hereditary
RT   breast cancer patients: a case-control study.";
RL   BMC Cancer 14:850-850(2014).
RN   [13]
RP   FUNCTION, AND MUTAGENESIS OF 2540-ASP-GLU-2541.
RX   PubMed=24648516; DOI=10.1074/jbc.m114.556977;
RA   Yoon J.H., Roy Choudhury J., Park J., Prakash S., Prakash L.;
RT   "A role for DNA polymerase theta in promoting replication through oxidative
RT   DNA lesion, thymine glycol, in human cells.";
RL   J. Biol. Chem. 289:13177-13185(2014).
RN   [14]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH ORC2 AND ORC4.
RX   PubMed=24989122; DOI=10.1038/ncomms5285;
RA   Fernandez-Vidal A., Guitton-Sert L., Cadoret J.C., Drac M., Schwob E.,
RA   Baldacci G., Cazaux C., Hoffmann J.S.;
RT   "A role for DNA polymerase theta in the timing of DNA replication.";
RL   Nat. Commun. 5:4285-4285(2014).
RN   [15]
RP   FUNCTION, INTERACTION WITH RAD51, AND SUBCELLULAR LOCATION.
RX   PubMed=25642963; DOI=10.1038/nature14184;
RA   Ceccaldi R., Liu J.C., Amunugama R., Hajdu I., Primack B., Petalcorin M.I.,
RA   O'Connor K.W., Konstantinopoulos P.A., Elledge S.J., Boulton S.J.,
RA   Yusufzai T., D'Andrea A.D.;
RT   "Homologous-recombination-deficient tumours are dependent on Poltheta-
RT   mediated repair.";
RL   Nature 518:258-262(2015).
RN   [16]
RP   FUNCTION, SUBUNIT, AND DOMAIN.
RX   PubMed=25643323; DOI=10.1038/nsmb.2961;
RA   Kent T., Chandramouly G., McDevitt S.M., Ozdemir A.Y., Pomerantz R.T.;
RT   "Mechanism of microhomology-mediated end-joining promoted by human DNA
RT   polymerase theta.";
RL   Nat. Struct. Mol. Biol. 22:230-237(2015).
CC   -!- FUNCTION: DNA polymerase that promotes microhomology-mediated end-
CC       joining (MMEJ), an alternative non-homologous end-joining (NHEJ)
CC       machinery triggered in response to double-strand breaks in DNA
CC       (PubMed:25642963, PubMed:25643323). MMEJ is an error-prone repair
CC       pathway that produces deletions of sequences from the strand being
CC       repaired and promotes genomic rearrangements, such as telomere fusions,
CC       some of them leading to cellular transformation (PubMed:25642963,
CC       PubMed:25643323). POLQ acts as an inhibitor of homology-recombination
CC       repair (HR) pathway by limiting RAD51 accumulation at resected ends
CC       (PubMed:25642963). POLQ-mediated MMEJ may be required to promote the
CC       survival of cells with a compromised HR repair pathway, thereby
CC       preventing genomic havoc by resolving unrepaired lesions (By
CC       similarity). The polymerase acts by binding directly the 2 ends of
CC       resected double-strand breaks, allowing microhomologous sequences in
CC       the overhangs to form base pairs. It then extends each strand from the
CC       base-paired region using the opposing overhang as a template. Requires
CC       partially resected DNA containing 2 to 6 base pairs of microhomology to
CC       perform MMEJ (PubMed:25643323). The polymerase activity is highly
CC       promiscuous: unlike most polymerases, promotes extension of ssDNA and
CC       partial ssDNA (pssDNA) substrates (PubMed:18503084, PubMed:21050863,
CC       PubMed:22135286). Also exhibits low-fidelity DNA synthesis, translesion
CC       synthesis and lyase activity, and it is implicated in interstrand-
CC       cross-link repair, base excision repair and DNA end-joining
CC       (PubMed:14576298, PubMed:18503084, PubMed:19188258, PubMed:24648516).
CC       Involved in somatic hypermutation of immunoglobulin genes, a process
CC       that requires the activity of DNA polymerases to ultimately introduce
CC       mutations at both A/T and C/G base pairs (By similarity).
CC       {ECO:0000250|UniProtKB:Q8CGS6, ECO:0000269|PubMed:14576298,
CC       ECO:0000269|PubMed:18503084, ECO:0000269|PubMed:19188258,
CC       ECO:0000269|PubMed:21050863, ECO:0000269|PubMed:22135286,
CC       ECO:0000269|PubMed:24648516, ECO:0000269|PubMed:25642963,
CC       ECO:0000269|PubMed:25643323}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339,
CC         Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:173112; EC=2.7.7.7;
CC         Evidence={ECO:0000269|PubMed:14576298, ECO:0000269|PubMed:22135286};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.095 uM for dATP:T {ECO:0000269|PubMed:22135286};
CC         KM=0.622 uM for dATP: abasic site {ECO:0000269|PubMed:22135286};
CC         KM=3.08 uM for dGTP: no template {ECO:0000269|PubMed:22135286};
CC   -!- SUBUNIT: Homomultimer; forms dimers and multimers (PubMed:25643323).
CC       Interacts with RAD51 (PubMed:25642963). Interacts with ORC2 and ORC4
CC       (PubMed:24989122). {ECO:0000269|PubMed:24989122,
CC       ECO:0000269|PubMed:25642963, ECO:0000269|PubMed:25643323}.
CC   -!- INTERACTION:
CC       O75417-1; O75417-1: POLQ; NbExp=5; IntAct=EBI-16141065, EBI-16141065;
CC       O75417-1; Q06609: RAD51; NbExp=3; IntAct=EBI-16141065, EBI-297202;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O18475}.
CC       Chromosome {ECO:0000269|PubMed:25642963}. Note=Enriched in chromatin in
CC       response to ultaviolet (UV) light (PubMed:25642963). Binds to chromatin
CC       during early G1 (PubMed:24989122). {ECO:0000269|PubMed:24989122,
CC       ECO:0000269|PubMed:25642963}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75417-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75417-2; Sequence=VSP_040747, VSP_040748;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis.
CC       {ECO:0000269|PubMed:14576298}.
CC   -!- DOMAIN: The loop 2 region is involved in the binding of the 2 ends of
CC       resected double-strand breaks and homomultimerization.
CC       {ECO:0000269|PubMed:25643323}.
CC   -!- DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy
CC       originating from breast epithelial tissue. Breast neoplasms can be
CC       distinguished by their histologic pattern. Invasive ductal carcinoma is
CC       by far the most common type. Breast cancer is etiologically and
CC       genetically heterogeneous. Important genetic factors have been
CC       indicated by familial occurrence and bilateral involvement. Mutations
CC       at more than one locus can be involved in different families or even in
CC       the same case. {ECO:0000269|PubMed:20624954,
CC       ECO:0000269|PubMed:20700469, ECO:0000269|PubMed:25409685}. Note=The
CC       gene represented in this entry may be involved in disease pathogenesis.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-A family. {ECO:0000305}.
CC   -!- CAUTION: Was wrongly named DNA polymerase eta (POLH) somne authors
CC       (Ref.4). This protein corresponds to DNA polymerase theta (POLQ) and
CC       should not be confused with DNA polymerase eta (POLH) (AC Q9Y253).
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD05272.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF052573; AAC33565.1; -; mRNA.
DR   EMBL; AY338826; AAR08421.2; -; mRNA.
DR   EMBL; AC069239; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079841; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF043628; AAD05272.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS33833.1; -. [O75417-1]
DR   RefSeq; NP_955452.3; NM_199420.3. [O75417-1]
DR   PDB; 4X0P; X-ray; 3.91 A; A/B/C/D=1792-2590.
DR   PDB; 4X0Q; X-ray; 3.90 A; A/B=1819-2590.
DR   PDB; 5A9F; X-ray; 3.20 A; A=67-894.
DR   PDB; 5A9J; X-ray; 3.55 A; A/B/C/D=1-894.
DR   PDB; 5AGA; X-ray; 2.90 A; A=67-894.
DR   PDB; 7ZUS; X-ray; 2.26 A; AAA/BBB/CCC=1820-2590.
DR   PDB; 7ZX0; X-ray; 2.99 A; AAA/BBB/CCC/DDD/EEE/FFF=1820-2590.
DR   PDB; 7ZX1; X-ray; 2.83 A; AAA/BBB/CCC/DDD/EEE/FFF=1820-2590.
DR   PDB; 8E23; X-ray; 2.59 A; A/D=1818-2590.
DR   PDB; 8E24; X-ray; 2.34 A; A/D=1818-2590.
DR   PDBsum; 4X0P; -.
DR   PDBsum; 4X0Q; -.
DR   PDBsum; 5A9F; -.
DR   PDBsum; 5A9J; -.
DR   PDBsum; 5AGA; -.
DR   PDBsum; 7ZUS; -.
DR   PDBsum; 7ZX0; -.
DR   PDBsum; 7ZX1; -.
DR   PDBsum; 8E23; -.
DR   PDBsum; 8E24; -.
DR   AlphaFoldDB; O75417; -.
DR   SMR; O75417; -.
DR   BioGRID; 115946; 16.
DR   DIP; DIP-61500N; -.
DR   IntAct; O75417; 3.
DR   STRING; 9606.ENSP00000264233; -.
DR   ChEMBL; CHEMBL6025; -.
DR   GlyGen; O75417; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; O75417; -.
DR   PhosphoSitePlus; O75417; -.
DR   BioMuta; POLQ; -.
DR   CPTAC; CPTAC-5890; -.
DR   EPD; O75417; -.
DR   jPOST; O75417; -.
DR   MassIVE; O75417; -.
DR   MaxQB; O75417; -.
DR   PaxDb; O75417; -.
DR   PeptideAtlas; O75417; -.
DR   ProteomicsDB; 49988; -. [O75417-1]
DR   ProteomicsDB; 49989; -. [O75417-2]
DR   Antibodypedia; 32825; 85 antibodies from 23 providers.
DR   DNASU; 10721; -.
DR   Ensembl; ENST00000264233.6; ENSP00000264233.5; ENSG00000051341.15. [O75417-1]
DR   GeneID; 10721; -.
DR   KEGG; hsa:10721; -.
DR   MANE-Select; ENST00000264233.6; ENSP00000264233.5; NM_199420.4; NP_955452.3.
DR   UCSC; uc003eee.5; human. [O75417-1]
DR   AGR; HGNC:9186; -.
DR   CTD; 10721; -.
DR   DisGeNET; 10721; -.
DR   GeneCards; POLQ; -.
DR   HGNC; HGNC:9186; POLQ.
DR   HPA; ENSG00000051341; Tissue enhanced (bone marrow, lymphoid tissue).
DR   MIM; 114480; phenotype.
DR   MIM; 604419; gene.
DR   neXtProt; NX_O75417; -.
DR   OpenTargets; ENSG00000051341; -.
DR   PharmGKB; PA33506; -.
DR   VEuPathDB; HostDB:ENSG00000051341; -.
DR   eggNOG; KOG0950; Eukaryota.
DR   GeneTree; ENSGT00940000158694; -.
DR   HOGENOM; CLU_000818_0_1_1; -.
DR   InParanoid; O75417; -.
DR   OrthoDB; 208079at2759; -.
DR   PhylomeDB; O75417; -.
DR   TreeFam; TF105018; -.
DR   PathwayCommons; O75417; -.
DR   Reactome; R-HSA-5685939; HDR through MMEJ (alt-NHEJ).
DR   SABIO-RK; O75417; -.
DR   SignaLink; O75417; -.
DR   BioGRID-ORCS; 10721; 114 hits in 1159 CRISPR screens.
DR   ChiTaRS; POLQ; human.
DR   GeneWiki; POLQ; -.
DR   GenomeRNAi; 10721; -.
DR   Pharos; O75417; Tbio.
DR   PRO; PR:O75417; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; O75417; protein.
DR   Bgee; ENSG00000051341; Expressed in secondary oocyte and 112 other tissues.
DR   Genevisible; O75417; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0051575; F:5'-deoxyribose-5-phosphate lyase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; TAS:ProtInc.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0017116; F:single-stranded DNA helicase activity; IDA:UniProtKB.
DR   GO; GO:0006284; P:base-excision repair; IDA:UniProtKB.
DR   GO; GO:0006974; P:DNA damage response; IDA:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0006261; P:DNA-templated DNA replication; IEA:InterPro.
DR   GO; GO:0006302; P:double-strand break repair; IDA:UniProtKB.
DR   GO; GO:0097681; P:double-strand break repair via alternative nonhomologous end joining; IDA:UniProtKB.
DR   GO; GO:2000042; P:negative regulation of double-strand break repair via homologous recombination; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0016446; P:somatic hypermutation of immunoglobulin genes; ISS:UniProtKB.
DR   CDD; cd18026; DEXHc_POLQ-like; 1.
DR   CDD; cd08638; DNA_pol_A_theta; 1.
DR   CDD; cd18795; SF2_C_Ski2; 1.
DR   Gene3D; 1.10.3380.20; -; 1.
DR   Gene3D; 3.30.70.370; -; 1.
DR   Gene3D; 1.10.150.20; 5' to 3' exonuclease, C-terminal subdomain; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   Gene3D; 3.30.420.10; Ribonuclease H-like superfamily/Ribonuclease H; 1.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR019760; DNA-dir_DNA_pol_A_CS.
DR   InterPro; IPR001098; DNA-dir_DNA_pol_A_palm_dom.
DR   InterPro; IPR043502; DNA/RNA_pol_sf.
DR   InterPro; IPR002298; DNA_polymerase_A.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR046931; HTH_61.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   InterPro; IPR036397; RNaseH_sf.
DR   PANTHER; PTHR10133; DNA POLYMERASE I; 1.
DR   PANTHER; PTHR10133:SF62; DNA POLYMERASE THETA; 1.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF00476; DNA_pol_A; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   Pfam; PF20470; HTH_61; 1.
DR   PRINTS; PR00868; DNAPOLI.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SMART; SM00482; POLAc; 1.
DR   SUPFAM; SSF56672; DNA/RNA polymerases; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF53098; Ribonuclease H-like; 1.
DR   SUPFAM; SSF158702; Sec63 N-terminal domain-like; 1.
DR   PROSITE; PS00447; DNA_POLYMERASE_A; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Chromosome;
KW   Coiled coil; DNA damage; DNA repair; DNA-directed DNA polymerase;
KW   Nucleotide-binding; Nucleotidyltransferase; Nucleus; Reference proteome;
KW   Transferase.
FT   CHAIN           1..2590
FT                   /note="DNA polymerase theta"
FT                   /id="PRO_0000101279"
FT   DOMAIN          102..286
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          321..554
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   REGION          1..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          847..894
FT                   /note="Interaction with RAD51"
FT                   /evidence="ECO:0000269|PubMed:25642963"
FT   REGION          1034..1060
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1594..1622
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1777..1797
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2142..2177
FT                   /note="Loop 1"
FT                   /evidence="ECO:0000269|PubMed:21050863"
FT   REGION          2257..2322
FT                   /note="Loop 2"
FT                   /evidence="ECO:0000269|PubMed:21050863,
FT                   ECO:0000269|PubMed:25643323"
FT   REGION          2491..2535
FT                   /note="Loop 3"
FT                   /evidence="ECO:0000269|PubMed:21050863"
FT   COILED          1655..1716
FT                   /evidence="ECO:0000255"
FT   MOTIF           216..219
FT                   /note="DEAH box"
FT   COMPBIAS        17..33
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1594..1621
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1782..1797
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         115..122
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   MOD_RES         990
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   VAR_SEQ         1..828
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10395804"
FT                   /id="VSP_040747"
FT   VAR_SEQ         829..840
FT                   /note="VEVILKNAVPFK -> MNSFLSFPISLC (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10395804"
FT                   /id="VSP_040748"
FT   VARIANT         1056
FT                   /note="P -> L (in dbSNP:rs34778629)"
FT                   /id="VAR_055707"
FT   MUTAGEN         2540..2541
FT                   /note="DE->AA: Abolishes DNA polymerase activity."
FT                   /evidence="ECO:0000269|PubMed:19188258,
FT                   ECO:0000269|PubMed:24648516"
FT   CONFLICT        66
FT                   /note="R -> I (in Ref. 2; AAR08421)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        982
FT                   /note="T -> R (in Ref. 2; AAR08421)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2013
FT                   /note="L -> F (in Ref. 4; AAD05272)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2513
FT                   /note="Q -> R (in Ref. 1; AAC33565 and 2; AAR08421)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2547
FT                   /note="A -> V (in Ref. 1; AAC33565)"
FT                   /evidence="ECO:0000305"
FT   HELIX           71..73
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           78..85
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           94..101
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          102..104
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   TURN            105..108
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          111..114
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           121..135
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          139..146
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           147..161
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           162..164
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          168..171
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           181..183
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          185..190
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           191..203
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           207..209
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          210..216
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           218..221
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           229..243
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           245..247
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          260..266
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           271..277
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          281..284
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          292..298
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          301..303
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          309..312
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           326..335
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          340..343
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           347..366
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          380..383
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           384..395
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           403..408
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           409..411
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          413..416
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           422..433
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          439..442
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           444..447
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          454..460
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          462..464
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           471..478
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   TURN            484..486
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          490..496
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          498..500
FT                   /evidence="ECO:0007829|PDB:5A9F"
FT   HELIX           501..509
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           529..540
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           547..556
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   TURN            559..562
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           581..591
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          594..598
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          607..611
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           613..620
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           625..638
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          645..647
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           648..653
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           666..674
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           678..687
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           691..698
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   TURN            708..711
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           712..728
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   TURN            729..731
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           734..741
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           745..768
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           772..778
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           781..787
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           791..794
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           796..798
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           804..811
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   TURN            812..814
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           818..822
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   HELIX           826..834
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          840..842
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          856..858
FT                   /evidence="ECO:0007829|PDB:5A9F"
FT   HELIX           872..889
FT                   /evidence="ECO:0007829|PDB:5AGA"
FT   STRAND          1826..1829
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           1830..1832
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           1834..1844
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          1848..1858
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   TURN            1862..1864
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          1896..1908
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          1911..1916
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           1941..1951
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          1961..1963
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           1967..1976
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          1983..1987
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           1989..1995
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2005..2012
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2014..2020
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2024..2027
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2028..2030
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   TURN            2032..2034
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2038..2040
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2042..2066
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2070..2075
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2077..2090
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2092..2094
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2096..2121
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2130..2137
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   TURN            2138..2140
FT                   /evidence="ECO:0007829|PDB:8E23"
FT   HELIX           2181..2186
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   TURN            2188..2190
FT                   /evidence="ECO:0007829|PDB:8E23"
FT   HELIX           2193..2209
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2211..2217
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2218..2221
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   TURN            2222..2225
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2226..2229
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2232..2234
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2238..2240
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2243..2247
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2249..2251
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2256..2260
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2306..2312
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2314..2317
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2324..2333
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2334..2343
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2346..2354
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2358..2366
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2371..2373
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2376..2390
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2395..2402
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2406..2419
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2421..2437
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2438..2441
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2447..2449
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2451..2454
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2458..2495
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2502..2507
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2531..2537
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2539..2547
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2548..2550
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   HELIX           2551..2563
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2574..2581
FT                   /evidence="ECO:0007829|PDB:8E24"
FT   STRAND          2586..2588
FT                   /evidence="ECO:0007829|PDB:8E24"
SQ   SEQUENCE   2590 AA;  289619 MW;  F5550BED2DAD8013 CRC64;
     MNLLRRSGKR RRSESGSDSF SGSGGDSSAS PQFLSGSVLS PPPGLGRCLK AAAAGECKPT
     VPDYERDKLL LANWGLPKAV LEKYHSFGVK KMFEWQAECL LLGQVLEGKN LVYSAPTSAG
     KTLVAELLIL KRVLEMRKKA LFILPFVSVA KEKKYYLQSL FQEVGIKVDG YMGSTSPSRH
     FSSLDIAVCT IERANGLINR LIEENKMDLL GMVVVDELHM LGDSHRGYLL ELLLTKICYI
     TRKSASCQAD LASSLSNAVQ IVGMSATLPN LELVASWLNA ELYHTDFRPV PLLESVKVGN
     SIYDSSMKLV REFEPMLQVK GDEDHVVSLC YETICDNHSV LLFCPSKKWC EKLADIIARE
     FYNLHHQAEG LVKPSECPPV ILEQKELLEV MDQLRRLPSG LDSVLQKTVP WGVAFHHAGL
     TFEERDIIEG AFRQGLIRVL AATSTLSSGV NLPARRVIIR TPIFGGRPLD ILTYKQMVGR
     AGRKGVDTVG ESILICKNSE KSKGIALLQG SLKPVRSCLQ RREGEEVTGS MIRAILEIIV
     GGVASTSQDM HTYAACTFLA ASMKEGKQGI QRNQESVQLG AIEACVMWLL ENEFIQSTEA
     SDGTEGKVYH PTHLGSATLS SSLSPADTLD IFADLQRAMK GFVLENDLHI LYLVTPMFED
     WTTIDWYRFF CLWEKLPTSM KRVAELVGVE EGFLARCVKG KVVARTERQH RQMAIHKRFF
     TSLVLLDLIS EVPLREINQK YGCNRGQIQS LQQSAAVYAG MITVFSNRLG WHNMELLLSQ
     FQKRLTFGIQ RELCDLVRVS LLNAQRARVL YASGFHTVAD LARANIVEVE VILKNAVPFK
     SARKAVDEEE EAVEERRNMR TIWVTGRKGL TEREAAALIV EEARMILQQD LVEMGVQWNP
     CALLHSSTCS LTHSESEVKE HTFISQTKSS YKKLTSKNKS NTIFSDSYIK HSPNIVQDLN
     KSREHTSSFN CNFQNGNQEH QTCSIFRARK RASLDINKEK PGASQNEGKT SDKKVVQTFS
     QKTKKAPLNF NSEKMSRSFR SWKRRKHLKR SRDSSPLKDS GACRIHLQGQ TLSNPSLCED
     PFTLDEKKTE FRNSGPFAKN VSLSGKEKDN KTSFPLQIKQ NCSWNITLTN DNFVEHIVTG
     SQSKNVTCQA TSVVSEKGRG VAVEAEKINE VLIQNGSKNQ NVYMKHHDIH PINQYLRKQS
     HEQTSTITKQ KNIIERQMPC EAVSSYINRD SNVTINCERI KLNTEENKPS HFQALGDDIS
     RTVIPSEVLP SAGAFSKSEG QHENFLNISR LQEKTGTYTT NKTKNNHVSD LGLVLCDFED
     SFYLDTQSEK IIQQMATENA KLGAKDTNLA AGIMQKSLVQ QNSMNSFQKE CHIPFPAEQH
     PLGATKIDHL DLKTVGTMKQ SSDSHGVDIL TPESPIFHSP ILLEENGLFL KKNEVSVTDS
     QLNSFLQGYQ TQETVKPVIL LIPQKRTPTG VEGECLPVPE TSLNMSDSLL FDSFSDDYLV
     KEQLPDMQMK EPLPSEVTSN HFSDSLCLQE DLIKKSNVNE NQDTHQQLTC SNDESIIFSE
     MDSVQMVEAL DNVDIFPVQE KNHTVVSPRA LELSDPVLDE HHQGDQDGGD QDERAEKSKL
     TGTRQNHSFI WSGASFDLSP GLQRILDKVS SPLENEKLKS MTINFSSLNR KNTELNEEQE
     VISNLETKQV QGISFSSNNE VKSKIEMLEN NANHDETSSL LPRKESNIVD DNGLIPPTPI
     PTSASKLTFP GILETPVNPW KTNNVLQPGE SYLFGSPSDI KNHDLSPGSR NGFKDNSPIS
     DTSFSLQLSQ DGLQLTPASS SSESLSIIDV ASDQNLFQTF IKEWRCKKRF SISLACEKIR
     SLTSSKTATI GSRFKQASSP QEIPIRDDGF PIKGCDDTLV VGLAVCWGGR DAYYFSLQKE
     QKHSEISASL VPPSLDPSLT LKDRMWYLQS CLRKESDKEC SVVIYDFIQS YKILLLSCGI
     SLEQSYEDPK VACWLLDPDS QEPTLHSIVT SFLPHELPLL EGMETSQGIQ SLGLNAGSEH
     SGRYRASVES ILIFNSMNQL NSLLQKENLQ DVFRKVEMPS QYCLALLELN GIGFSTAECE
     SQKHIMQAKL DAIETQAYQL AGHSFSFTSS DDIAEVLFLE LKLPPNREMK NQGSKKTLGS
     TRRGIDNGRK LRLGRQFSTS KDVLNKLKAL HPLPGLILEW RRITNAITKV VFPLQREKCL
     NPFLGMERIY PVSQSHTATG RITFTEPNIQ NVPRDFEIKM PTLVGESPPS QAVGKGLLPM
     GRGKYKKGFS VNPRCQAQME ERAADRGMPF SISMRHAFVP FPGGSILAAD YSQLELRILA
     HLSHDRRLIQ VLNTGADVFR SIAAEWKMIE PESVGDDLRQ QAKQICYGII YGMGAKSLGE
     QMGIKENDAA CYIDSFKSRY TGINQFMTET VKNCKRDGFV QTILGRRRYL PGIKDNNPYR
     KAHAERQAIN TIVQGSAADI VKIATVNIQK QLETFHSTFK SHGHREGMLQ SDQTGLSRKR
     KLQGMFCPIR GGFFILQLHD ELLYEVAEED VVQVAQIVKN EMESAVKLSV KLKVKVKIGA
     SWGELKDFDV
//
